FREE SHIPPING ON ORDERS OVER $150

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

$28.00

Quantity
- +
Description

A key function of GLP-1 is to lower blood sugar levels, achieved through stimulating insulin production by the pancreas in response to high blood sugar, and inhibiting glucagon secretion, which otherwise raises blood sugar levels by promoting glucose production in the liver

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

Cardiovascular benefits

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

Persson, S.C

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

All types of research reports, including case reports and case series, were included

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

The mean patient age ranged between 34 and 57 years

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

Stroke Vasc Neurol

dual gip/glp-1 receptor agonist agonists: New advances for treating type-2 diabetes Tirzepatide, a dual GIP/GLP-1 receptor

You may also like

recommand products